AARTIIND2020-07-012020-09-30in-bse-fin:OneOperatingExpenses01Member AARTIIND2020-07-012020-09-30in-bse-fin:FourOperatingExpenses01Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentRevenue01Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentRevenue02Member AARTIIND2020-07-012020-09-30in-bse-fin:FourReportableSegmentRevenue01Member AARTIIND2020-07-012020-09-30in-bse-fin:FourReportableSegmentRevenue02Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentResults01Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentResults02Member AARTIIND2020-07-012020-09-30in-bse-fin:FourReportableSegmentResults01Member AARTIIND2020-07-012020-09-30in-bse-fin:FourReportableSegmentResults02Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentAssets01Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentAssets02Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentLiabilities01Member AARTIIND2020-09-30in-bse-fin:OneReportableSegmentLiabilities01Member AARTIIND2020-07-012020-09-30in-bse-fin:OneReportableSegmentLiabilities02Member AARTIIND2020-09-30in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AARTIIND 2020-04-01 2021-03-31 2020-10-29 INR Lakhs Half yearly true Cash Flow Indirect Multi segment 2020-07-01 2020-09-30 Audited Standalone 11261300000.00 200000.00 11261500000.00 4847400000.00 548000000.00 181500000.00 904500000.00 215400000.00 517900000.00 2373000000.00 9587700000.00 1673800000.00 0.00 1673800000.00 285000000.00 25000000.00 310000000.00 0.00 1363800000.00 0.00 0.00 0.00 0.00 1363800000.00 183800000.00 1547600000.00 1547600000.00 0.00 871200000.00 5 7.83 7.83 0.00 0.00 7.83 7.83 0.00 0.03 0.09 Notes: n n1. The above results for the quarter and half year ended 30th September, 2020 have been reviewed by the Audit Committee in their meeting and approved by the Board of Directors in their meeting held on 10th November, 2020. n n2. The Board of Directors have declared Interim Dividend of Rs. 1.50/- per Equity Shares of Rs. 5/- each (30%) amounting to Rs. 26,13,51,711/- and fixed the Friday, November 20, 2020 as the record date in this regard. n n3. The Company has entered into forward contracts to hedge its export contracts. Mark to market gain/(loss) for such contracts as at the end of reporting period is recognised in these statements. Mark to market gain/(loss) in respect of near term contracts amounting to Rs. 71 Lakhs is expensed off in the above P&L statement, while mark to market gain/(loss) in respect of long term contracts amounting to (Rs. 86) Lakhs is adjusted under Other Comprehensive Income. The component adjusted under Other Comprehensive Income will appropriately be treated in P&L when the underlying cash-flow impact accrues. n n4. The Company has further recognised revaluation gain/(loss) to the extent of Rs.593 Lakhs in respect of its long term borrowings (ECBs) as at 30th September, 2020 and included the same in its Finance Costs appearing above. n n5. The Company has retained its domestic credit ratings of AA/Stable from India Ratings and CRISIL has upgraded Long term issuers ratings of the Company from AA-/Positive to AA/Stable. n n6. Formulae for computation of ratios are as follows: n nDebt Service Coverage Ratio = Earnings before Interest and Tax/(Interest Expenses + Principal Repayment of Term loan during the period) n nInterest Service Coverage Ratio = Earnings before Interest and Tax/Interest Expenses for the period) n n7. The Company has maintained Capital Redemption Reserve / Debenture redemption reserve and Debt-Equity as per below: n nParticulars 6 Months n 30th September, 2020 n Standalone Consolidated n nCapital Redemption Reserve/Debenture Redemption Reserve 0.00 71 nGross Debt-Equity Ratio 0.78 0.74 n n8. The Company has repaid Commercial Papers on their respective due dates. The Commercial Papers (Listed) outstanding as on 30th September, 2020 was Rs. 30000 Lakhs. The Commercial paper (Short Term Debt) have been rated by both India Rating and Crisil Limited and the rating assigned is A1+ by both the rating agencies. n n9. The Company is in compliance with requirements of SEBI circular dated November 26, 2018 applicable to large corporate borrowers with credit rating of AA and above. n n10. Figures for the previous period have been regrouped or rearranged wherever necessary. n n11. The aforesaid Audited Financial Results will be uploaded on the Company's website www.aarti-industries.com and will also be available on the website of BSE Limited www.bseindia.com and the National Stock Exchange of India Limited www.nseindia.com for the benefit of the shareholders and investors. n nFor AARTI INDUSTRIES LIMITED n nSd/- nRAJENDRA V. GOGRI nCHAIRMAN AND MANAGING DIRECTOR n nPlace: Mumbai nDate:10th November, 2020 Multi segment 2020-04-01 2020-09-30 Audited Standalone 20309700000.00 300000.00 20310000000.00 9084400000.00 1005800000.00 -185600000.00 1772400000.00 467300000.00 1005600000.00 4466600000.00 17616500000.00 2693500000.00 0.00 2693500000.00 460000000.00 55000000.00 515000000.00 0.00 2178500000.00 0.00 0.00 0.00 0.00 2178500000.00 271500000.00 2450000000.00 2450000000.00 0.00 871200000.00 5 12.50 12.50 0.00 0.00 12.50 12.50 0.01 0.02 0.07 Other Expenses 2373000000.00 Other Expenses 4466600000.00 a) Speciality Chemicals 9260900000.00 b) Pharmaceuticals 2000400000.00 a) Speciality Chemicals 16494300000.00 b) Pharmaceuticals 3815400000.00 11261300000.00 20309700000.00 0.00 0.00 11261300000.00 20309700000.00 a) Speciality Chemicals 1785200000.00 b) Pharmaceuticals 565200000.00 a) Speciality Chemicals 3039700000.00 b) Pharmaceuticals 1018300000.00 2350400000.00 4058000000.00 215400000.00 467300000.00 461200000.00 Notes: n nFigures for the previous period have been regrouped or rearranged wherever necessary. n nFor AARTI INDUSTRIES LIMITED n nSd/- nRAJENDRA V. GOGRI nCHAIRMAN AND MANAGING DIRECTOR n nPlace: Mumbai nDate:10th November, 2020 897200000.00 1673800000.00 2693500000.00 a) Speciality Chemicals 50002200000.00 b) Pharmaceuticals 10382200000.00 60384400000.00 3752400000.00 64136800000.00 a) Speciality Chemicals 10526700000.00 b) Pharmaceuticals 1212100000.00 11738800000.00 2009800000.00 13748600000.00 467300000.00 -381600000.00 0.00 -698600000.00 0.00 0.00 0.00 0.00 0.00 -260400000.00 0.00 0.00 0.00 1005600000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -300000.00 0.00 0.00 132000000.00 2825500000.00 0.00 0.00 0.00 507300000.00 0.00 2318200000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5264500000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 300000.00 0.00 -5264200000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4681800000.00 902600000.00 0.00 0.00 174200000.00 467300000.00 0.00 0.00 3137700000.00 191700000.00 0.00 191700000.00 2333700000.00 2525400000.00